Nieuws en video's - SEER INC. - Pagina 2

U bekijkt momenteel alle beurs nieuws van het financieel instrument SEER INC. over alle markten in alle talen.

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions • • GlobeNewsWire • Aandelen

New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting proteomic studies full-service access to the Seer Proteograph™ Product Suite and mass spectrometry REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced the launch of the Seer Technology Access Center (STAC) in Bonn, Germany, providing the European biopharma and...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report First Quarter 2024 Financial Results on May 8, 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2024 on Wednesday, May 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2023. Recent Highlights Achieved revenue of $4.4 million for the fourth quarter of 2023, a decrease of 4% over the fourth quarter of 2022, and $16.7 million for the full year 2023, an increase of 8% over the full year 2022 Shipped 23...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in the TD Cowen 44th Annual Health Care Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 44 th Annual Health Care Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat and Q&A session on Monday, March 4 th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. A live webcast of the session will be...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery • • GlobeNewsWire • Aandelen

Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci (pQTL) studies Proteograph Product Suite enables scalable deep, unbiased proteomics by mass spectrometry and overcomes the limitations of affinity-based methods REDWOOD CITY, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P. Morgan 42 nd Annual Health Care Conference in San Francisco, CA. Seer’s management is scheduled to present and participate in a Q&A session on Wednesday, January 10 th at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern Time. A live webcast of the session...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the upcoming Canaccord MedTech, Diagnostics and Digital Health and Services Forum in New York, NY. Seer’s management is scheduled to present on Thursday, November 16 th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time. A live webcast of the session will be...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc . (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company was selected as “Proteomics Solution of the Year” in the 2023 BioTech Breakthrough Awards program as well as being named to the 2023 Deloitte Technology Fast 500 . “After launching our Proteograph XT Assay Kit this year, we continue to gain momentum in our efforts to open up a new...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Third Quarter 2023 Financial Results • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Achieved revenue of $4.2 million for the third quarter of 2023, an increase of 5% over the prior year period Expanded geographically with two new partners - Danyel Biotech in Israel and GeneTiCA in Eastern Europe Added Panome Bio to...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio has joined its COE Program. Panome Bio is a metabolomics and proteomics services company that provides biopharma innovators unparalleled access to the biomolecules closest to phenotype using its proprietary Next Generation Metabolomics™ technology. Panome Bio joins Seer’s global COE network of...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the third quarter of 2023 after market close on Tuesday, November 7, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in Upcoming September Investor Conferences • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences: Morgan Stanley 21 st Annual Global Healthcare Conference in New York, NY. Fireside chat on Wednesday, September 13 th at 12:15 p.m. Eastern Time Gilmartin Group Emerging Growth Company Showcase, Virtual. Presentation on Thursday,...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Second Quarter 2023 Financial Results • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2023. Recent Highlights Achieved revenue of $4.0 million for the second quarter of 2023, an increase of 11% over the prior year period Launched the Proteograph XT Assay Kit, enabling rapid proteomics across a range of sample types and species with unprecedented...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 43 rd Annual Growth Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat on Thursday, August 10 th at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time. A live webcast of the session will be available...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Second Quarter 2023 Financial Results on August 8, 2023 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter of 2023 after market close on Tuesday, August 8, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc . (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced an expanded collaboration with Thermo Fisher Scientific, a world leader in serving science, to enable broader access to each company’s respective new technologies. As part of the collaboration, Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced the launch of the Proteograph XT Assay Kit , the latest proteomics assay workflow for the Proteograph Product Suite. This new product increases throughput without compromising performance, making it possible for a single user to process hundreds of samples per week, generating deep, unbiased proteomics data at scale....

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports First Quarter 2023 Financial Results • • GlobeNewsWire • Aandelen

Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2023. “We started the year off strong with continued growth in our installed base and progress against our strategic...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report First Quarter 2023 Financial Results on May 9, 2023 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter of 2023 after market close on Tuesday, May 9, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website...

Dank u Grafiek